Alliancebernstein L.P. Immunovant, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Immunovant, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 71,450 shares of IMVT stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,450

Previous 67,150 6.4%

Holding current value

$1.97 Million

Previous $2.17 Million 13.05%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $107,930 - $135,923	4,300 Added 6.4%	71,450 $1.89 Million
Q1 2024 May 14, 2024	SELL	$30.27 - $43.79 $172,841 - $250,040	-5,710 Reduced 7.84%	67,150 $2.17 Million
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $50,096 - $70,704	-1,600 Reduced 2.15%	72,860 $3.07 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $106,848 - $230,169	5,760 Added 8.38%	74,460 $2.86 Million
Q2 2023 Aug 15, 2023	BUY	$14.2 - $23.75 $161,880 - $270,750	11,400 Added 19.9%	68,700 $1.3 Million
Q1 2023 May 15, 2023	SELL	$15.27 - $19.72 $357,318 - $461,448	-23,400 Reduced 29.0%	57,300 $888,000
Q4 2022 Feb 14, 2023	SELL	$6.59 - $17.75 $34,927 - $94,075	-5,300 Reduced 6.16%	80,700 $1.43 Million
Q3 2022 Nov 15, 2022	BUY	$3.93 - $6.37 $9,432 - $15,288	2,400 Added 2.87%	86,000 $480,000
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.65 $11,830 - $19,775	3,500 Added 4.37%	83,600 $326,000
Q1 2022 May 13, 2022	BUY	$5.06 - $8.77 $1,011 - $1,754	200 Added 0.25%	80,100 $441,000
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $33,718 - $42,872	-4,600 Reduced 5.44%	79,900 $681,000
Q3 2021 Nov 10, 2021	SELL	$7.01 - $11.37 $56,080 - $90,960	-8,000 Reduced 8.65%	84,500 $734,000
Q2 2021 Jul 30, 2021	BUY	$9.4 - $16.85 $554,600 - $994,150	59,000 Added 176.12%	92,500 $978,000
Q1 2021 May 06, 2021	SELL	$13.08 - $49.6 $574,695 - $2.18 Million	-43,937 Reduced 56.74%	33,500 $537,000
Q4 2020 Feb 08, 2021	SELL	$36.36 - $52.71 $3.56 Million - $5.16 Million	-97,978 Reduced 55.85%	77,437 $3.58 Million
Q3 2020 Nov 12, 2020	BUY	$22.61 - $38.9 $1.51 Million - $2.6 Million	66,756 Added 61.44%	175,415 $6.17 Million
Q2 2020 Aug 13, 2020	BUY	$13.87 - $28.44 $742,114 - $1.52 Million	53,505 Added 97.01%	108,659 $2.65 Million
Q1 2020 May 14, 2020	BUY	$8.36 - $17.13 $461,087 - $944,788	55,154 New	55,154 $858,000

Others Institutions Holding IMVT

# of Institutions

220

Shares Held

65.1M

Call Options Held

697K

Put Options Held

629K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Immunovant, Inc. Transaction History